Nov 10 2022
A new study provides evidence “supporting efficacy and tolerability of a full-spectrum, high-CBD product for anxiety.” Published in the journal Communications Medicine and conducted by researchers at Harvard Medical School, the study is titled Clinical and cognitive improvement following full-spectrum, high-cannabidiol treatment for anxiety: open-label data from a two-stage, phase 2 clinical trial. The study …
Nov 07 2022
According to a study published in the peer-reviewed journal Cannabis and Cannabinoid Research and epublished ahead of print by the National Institute of Health, “medical cannabis may improve their quality of life and comorbidities” in those with Tourette’s syndrome. The study, titled Use of Medical Cannabis in Patients with Gilles de la Tourette’s Syndrome in …
Nov 07 2022
Cannabidiol (CBD) may alleviate liver and skin fibrosis according to a new study published by the peer-reviewed journal Frontiers in Pharmacology. “Cannabidiol (CBD) has been suggested as a potential therapy for inflammatory and fibrotic diseases”, states the study’s abstract. “Cannabidiol was demonstrated to reduce alcohol-induced liver inflammation and steatosis but its specific activity on the …
Nov 03 2022
According to a new study published in the Journal of Clinical Medicine, “cannabis use was associated with a lower risk of hypertension and a lower number of metabolic disorders” among those with the Hepatitis C virus. For the study researchers examined the relationship between current and/or lifetime cannabis use and metabolic disorders in a cohort …
Nov 02 2022
A large majority of patients with Fragile X Syndrome reported that CBD improved some of their symptoms and “made a positive difference overall” in a new study. The study was published in the journal Genes as well as on the website for the U.S. National Library of Medicine, and is titled Parent and Caregiver Perspectives …
Nov 01 2022
According to a new study published in the peer-reviewed Rambam Maimonides Medical Journal, smoking cannabis is more effective than taking CBD extracts if suffering from back pain. This observational open-label study “sought to investigate the effectiveness of cannabis therapy for alleviating low back pain symptoms.” The study was conducted by researchers at Tel Aviv University, …
Oct 27 2022
The state level legalization of recreational marijuana has no discernible impact on how children feel about the potential risks associated with marijuana use. This is according to a new peer-reviewed study being published in the upcoming issue of the journal Cannabis and Cannabinoid Research and epublished ahead of print by the National Institute of Health. …
Oct 24 2022
According to a new study published in the peer-reviewed journal Frontiers in Medicine, marijuana oil significantly reduced agitation and aggression and reduced sleep disturbances in patients with dementia. According to its abstract, the objective of the study was to “evaluate the safety and efficacy of the medical cannabis oil “Avidekel” for the reduction of behavioral …
Oct 23 2022
A new study published in the Journal of Clinical Gastroenterology has found that those with inflammatory bowel disease (IBD) report improved symptoms and fewer emergency room visits following marijuana use. Conducted by researchers at Albert Einstein College of Medicine, Northwestern University and Stony Brook University Hospital, the objective of the study according to its abstract …
Oct 21 2022
Cannabidiol (CBD) mitigated the neuronal damage caused by kainate in an in-vitro seizure model, according to a new study published in the peer-reviewed journal Neurobiology of Disease. The study states that epilepsy “is one of the most common brain disorder and, despite the possible use of several therapeutic options, many patients continue to have seizures …
